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The interest for natural antimicrobial compounds has increased due to alterations in consumer positions towards the use of
chemical preservatives in foodstuﬀ and food processing surfaces. Bacteriophages fit in the class of natural antimicrobial and their
eﬀectiveness in controlling bacterial pathogens in agro-food industry has led to the development of diﬀerent phage products
already approved by USFDA and USDA. The majority of these products are to be used in farm animals or animal products such
as carcasses, meats and also in agricultural and horticultural products. Treatment with specific phages in the food industry can
prevent the decay of products and the spread of bacterial diseases and ultimately promote safe environments in animal and plant
food production, processing, and handling. This is an overview of recent work carried out with phages as tools to promote food
safety, starting with a general introduction describing the prevalence of foodborne pathogens and bacteriophages and a more
detailed discussion on the use of phage therapy to prevent and treat experimentally induced infections of animals against the most
common foodborne pathogens, the use of phages as biocontrol agents in foods, and also their use as biosanitizers of food contact
surfaces.
1. Introduction
Everyday people worldwide buy and consume a diversity of
products of animal and plant origin expecting these products
to be safe. However, annually, millions of people become
ill, are hospitalized, and die due to a variety of foodborne
pathogens transmitted through foods. For instance, the
World Health Organization estimated in their fact sheet of
March 2007 (no. 237) that in 2005, over 1.8 million people
died due to diarrhoeal diseases. Furthermore, annually in the
USA alone, there are roughly 48 million illnesses, 128,000
hospitalizations, and even 3,000 deaths caused by foodborne
pathogens [1].
Regardless of modern technologies, good manufacturing
practices, quality control and hygiene, changes in animal
husbandry, agronomic process, and in food or agricul-
tural technology, food safety is continuously challenged by
changes in lifestyle and consumer demands (e.g., ready-to-
eat products) and also by the increase of international trade
[2]. The most eﬃcient means for limiting the growth of
microbes are good production hygiene, a rational running
of the process line, and a well-designed use of biocides and
disinfectants [3]. However, even when acceptable cleaning
procedures are applied, bacteria are found in foods and food
contact surfaces [4]. Food products may become contami-
nated at diﬀerent stages along the food chain, from growth
or production until the final consumption. Furthermore, the
inherent ability of pathogens to attach to living and inert
surfaces, where they start living in microbial communities
known as biofilms, and become highly tolerant to varied
antimicrobial agents [5] also contributes to the pathogen
prevalence in foods and food contact surfaces. So, to meet
the primary goal of any food safety program, the consumer
protection, new food preservation techniques have to be con-
tinually developed to meet current demands, in order to con-
trol the emerging pathogens and their impact at global scale.
2. Bacteriophage: Charting the Path to
Food Safety
(Bacterio)phage, viruses specifically infecting bacteria, are
harmless to humans, animals, and plants. Since the discovery
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of phages in 1915, they have been extensively used not
only in human and veterinary medicine but also in various
agricultural settings. Being obligatory parasites, upon mul-
tiplication by taking over host protein machinery, phages
can either cause cell lysis to release the newly formed virus
particles (lytic pathway) or lead to integration of the genetic
information into the bacterial chromosome without cell
death (lysogenic pathway).
Towards a food safety perspective, strictly lytic phages are
possibly one of the most harmless antibacterial approaches
available.
Phages oﬀer advantages as biocontrol agents for several
reasons: (i) high specificity to target their host determined by
bacterial cell wall receptors, leaving untouched the remain-
ing microbiota, a property that favors phages over other
antimicrobials that can cause microbiota collateral damage;
(ii) self-replication and self-limiting, meaning that low or
single dosages will multiply as long as there is still a host
threshold present, multiplying their overall antimicrobial
impact; (iii) as bacteria develop phage defense mechanisms
for their survival, phages continuously adapt to these altered
host systems; (iv) low inherent toxicity, since they consist
mostly of nucleic acids and proteins; (v) phages are relatively
cheap and easy to isolate and propagate butmay become time
consuming when considering the development of a highly
virulent, broad-spectrum, and nontransducing phage; (vi)
they can generally withstand food processing environmental
stresses (including food physiochemical conditions); (vii)
they have proved to have prolonged shelf life. Phages are
readily abundant in foods and have been isolated from a
wide variety of raw products (e.g., beef, chicken) [6, 7],
processed food (e.g., pies, biscuit dough, and roast turkey)
[8], fermented products (e.g., cheese, yoghurt) [9], and
seafood (e.g., mussels and oysters) [8, 10]. This suggests
that phages can be found in the same environments where
their bacterial host(s) inhabit, or once were present and that
phages are daily consumed by humans. Furthermore, the use
of antibiotics prophylactically and therapeutically in farm
animals has become a major concern due to their possibility
of contributing to the declining eﬃcacy of the antibiotics
used to treat bacterial infections in humans and leading
to the alarming emergence of superbugs like Salmonella
DT104 and the methicillin-resistant and multidrug-resistant
Staphylococcus aureus. The use of phages to promote food
safety can be basically done at four diﬀerent stages along the
food chain (Figure 1).
Reduction of pathogens colonization in animals during
primary production (phage therapy) is a strategy followed in
primary production just before slaughter or during animal
growth to reduce the probability of cross-contamination
with the animal feces during food processing. For example,
it is estimated that a reduction of 2 log on the Campylobacter
loads in poultry intestines is suﬃcient to diminish 30-
fold the incidence of campylobacteriosis associated with
consumption of chicken meals [11]. The proof of principle
of phage therapy in animals was already established for
several pathogens (detailed description below). Phages can
be administered orally, incorporated in drinking water or
food, to control Salmonella and Campylobacter in poultry,
or by spray to target avian pathogenic E. coli in poultry, and
orally/rectally to control E. coli in ruminants.
Reduction of colonization on foods (biocontrol) during
industrial food processing can be accomplished by applying
phages directly on food surfaces, for example, in case of
meats, fresh produce, and processed foods or even mixed
onto raw milk. Experimental data reveals that phages are
very eﬀective against actively growing bacteria and lose
eﬀectiveness in nongrowing bacteria [12]. In these cases,
eﬀective control could be achieved, applying high titres
of phages to control pathogens by “lysis from without”
mechanisms [6, 13] or whenever phages start to replicate
immediately after the food begins to warm (i.e., during
preparation, handling, and/or consumption).
In food industry, biofilms are found on the surfaces of
equipment used, for example, in food handling, storage, or
processing, especially in sites that are not easy to clean or
to sanitize. Some of the work using phages against in vitro
biofilms formed by spoilage and pathogenic bacteria show
that under ideal conditions significant viable cell reductions
are achieved and thus, their use for biosanitation is promising
although very challenging due to the diversity of bacteria
found in diﬀerent settings.
Phages are also excellent as food biopreservation agents
since they are reported to lyse hosts at temperatures as low
as 1◦C [14, 15], limiting growth of pathogenic and spoilage
bacteria on refrigerated foods (specially psychrotrophic
bacteria); once the foods are taken to room temperature,
phages can further control their proliferation [16].
3. Phages Targeting Different Food Pathogens
The global incidence of foodborne disease and costs associ-
ated are diﬃcult to estimate, however cost at least $7 billion
dollars each year in medical expenses and lost productivity in
the United States according to the United States Department
of Agriculture’s Economic Research Service [17]. The actual
figure is higher since this estimate reflects illnesses caused
only by the major foodborne pathogens. Themost frequently
reported pathogens from animal origin, responsible for such
impact, are separately discussed in this section, focusing on
their contamination sources and their harms for animals
and humans and furthermore summarizing the recent phage
interventions and main outcomes. We also briefly address
some of the common phytopathogens and discuss phage
applications carried out in an attempt to decrease crop
diseases and product loss.
4. Foodborne Pathogens from Animal Origin
The four main foodborne pathogens from animal origin
are accounted to be E. coli, Campylobacter, Salmonella, and
Listeria. These bacteria are all common contaminants of
ruminants, poultry, and swine and are usually carried in
their gastrointestinal tract asymptomatically. Research on
the use of phages against foodborne pathogens from animal
origin has mainly focused on the optimization of preharvest
interventions where the phage administration routes and
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Figure 1: Feasible applications of phages along the food chain towards an increased food safety (adapted from Greer [18]).
delivery processes have received most attention and also
on the optimization of postharvest strategies. The usage
of phages as a preharvest strategy is made directly by
administering phages to livestock to prevent animal illness
and/or also to minimize the pathogen carriage in the gastro-
intestinal tract, thereby preventing pathogen entry to the
food supply. Postharvest strategies are based on the use of
phages directly on animal carcasses in an attempt to sanitize
the products.
Escherichia coli is a gram-negative bacterium. Serotype
O157 :H7 in particular, classified as Shiga toxin-producing
E. coli, is a well-known food poisoning pathogen. Its major
reservoir comprises ruminants and, as it can survive well
under intestinal conditions, if proper care is not taken during
slaughter, the contents of the intestines, fecal material, or
dust on the hide may contaminate meats [19]. The most
common route of E. coli transmission to humans is via
undercooked contaminated food, while water and raw milk
are assumed to be related to cross-contamination events, by
direct or indirect contact with feces. This microorganism is
highly virulent and a public health threat because ingestion
of a concentration as low as 10 cells is able to cause infection
[1, 20, 21].
Recent pre- and postharvest phage research targeting E.
coli is listed in Table 1.
Recent phage therapy to decrease E. coli levels on farm
animals has focused mainly on poultry and ruminants.
Application of phages to poultry has been successful to
prevent fatal respiratory infections in broiler chickens [22–
24]. Several diﬀerent approaches have been used; however,
aerosol spraying and intramuscular (i.m.) injection have
given the best results and reduced significantly the mortality
of broiler chicken. Despite these results, phage adminis-
tration via addition to bird drinking water proved to be
ineﬃcient in protecting the birds from fatal E. coli respiratory
infections.
Although some successful results of phage therapy in
ruminants have been reported using oral delivery of phages
via direct administration or addition to drinking water
and/or feed, the majority of the recently published papers
suggest that oral treatment is unsuccessful in reducing E. coli
levels (see Table 1).
The main speculated causes for the failure of oral
treatments have been reported to be (i) nonspecific binding
of phages to food particles and other debris in the rumen
and gastrointestinal tract [25]; (ii) phage inactivation upon
contact with the acidic conditions of the abomasum [26];
(iii) causing an insuﬃcient number of orally phages reaching
the gastrointestinal tract [27]. An interesting approach
to reduce coliphage inactivation has been described by
Stanford and colleagues in 2010. These authors successfully
encapsulated phages in polymeric matrices which resisted
in vitro acidic conditions and furthermore, once delivered
orally to steers caused reduction of E. coli levels [28].
Essentially, oral delivery of phages has reported to be
successful either using a cocktail of phages or combined
with rectal treatment. For instance, a combined oral/rectal
treatment using phages KH1, SH1 was able to reduce
E. coli levels compared to oral treatment alone or to
individual phage administration, but still this combined
oral/rectal treatment using a phage cocktail did not cause
total eradication of the pathogen from cattle [32]. Also, a
cocktail of phages CEV1 and CEV2 were reported to lead to
more than 99.9% of reduction of E. coli in sheep guts [36].
However, although reductions of E. coli levels in diﬀerent
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Table 1: Pre- and postharvest E. coli O157 :H7 phage applications.
Year Animal/product Phage(s) Strategy Main outcome Refs
Preharvest application
2002 Poultry (broiler chicken) SPR02
Air sac or drinking
water
Air sac inoculation prevented mortality. Drinking water
oﬀered no protection
[24]
2002 Poultry (broiler chicken) SPR02 and DAF6 Sprayed
Significant decrease of mortality but not complete
protection
[22]
2003 Poultry (broiler chicken) SPR02 and DAF6
Sprayed and i.m.
injection
Aerosol spray eﬀective only when applied immediately
after bird challenge with E. coli. A single i.m. injection
reduced mortality when applied immediately and 24
and 48 h after challenge
[23]
2003 Ruminant (lamb) DC22 Oral delivery No reduction of fecal shedding over 30 days [29]
2006 Poultry (broiler chicken) SPR02 and DAF6
i.m. injection into
the left thigh
Only high phage titers (108) reduced mortality [30]
2006 Ruminant (sheep) CEV1 Oral delivery 2 log CFU reduction within 2 days [31]
2006 Ruminant (cattle)
Phage cocktail
(KH1, SH1)
Oral/rectal delivery
(via drinking
water)
No reduction of CFU when applied orally. Combined
oral/rectal treatment reduced CFU but did not
eradicate it
[32]
2009 Ruminant (steer) Phage cocktail Oral/rectal delivery
Small fecal shedding reduction of oral/rectal compared
to the rectal treatment and control
[33]
2010 Ruminant (steer)
Phage cocktail (wV8,
rV5, wV7, wV11)
Oral delivery
(gelatin capsules
and in feed)
No reduction of fecal shedding of nalidixic
acid-resistant E. coli O157 :H7, but duration of
shedding was reduced by 14 days
[28]
2010 Poultry Phage cocktail
Oral delivery and
spray
Significant reduction of mortality in large scale animal
experiments
[34]
2010 Ruminant (cattle)
Phage cocktail (e11/2,
e4/1c)
Oral delivery
Rapid CFU decrease within 24 to 48 h, but no decrease
in fecal shedding levels
[35]
2011 Ruminant (sheep)
Phage cocktail (CEV1,
CEV2)
Oral delivery
Cocktail eradicated (>99.9%) the pathogen and is more
eﬀective than CEV1 alone
[36]
Postharvest application
2004 Meat e11/2, e4/1c, pp01 Applied on top Eradication in seven of nine samples [37]
2008
Fresh produce (tomato,
spinach) and meat
Phage cocktail
(ECP-100)
Applied on
top/sprayed
94% and 100% reductions in CFU after 120 h and 24 h
in tomato and spinach; 95% reduction in ground meat
after 24 h at 10◦C
[38]
2009
Fresh produce (lettuce,
cantaloupe)
Phage cocktail
(ECP-100)
Sprayed Significant CFU reductions after 2 days at 4◦C [39]
2011
Fresh produce (lettuce,
spinach)
Phage cocktail
(BEC8)
Added to foods
together with
trans-
cinnamaldehyde
(TC)
No survivors detectable after 10min of phage
combined with the TC treatment
[40]
2011
Food surfaces (spinach
blades)
Phage cocktail Sprayed 4.5 log reduction CFU after 2 h of phage [41]
2011
Food surfaces (steel,
ceramic chips)
Phage cocktail
(BEC8)
Applied on top Eradication after 10 min at 37◦C and after 1 h at 23◦C [40]
organs have been described, phages still fail in reducing
fecal shedding [29, 35], and only in one published work
the authors managed to reduce fecal shedding duration
by 14 days [28]. In 2008, Niu and colleagues investigated
two diﬀerent sampling techniques: fecal grab and rectoanal
mucosal swab for surveillance of E. coli O157 :H7 [42]
and to study the role of phage as a mitigation strategy.
Their study showed discrepancy between fecal and rectoanal
mucosal swab sampling in 63 of the 213 positive samples
from experimentally inoculated feedlot steer. This shows that
sampling procedures can significantly influence the merit of
phage and that prudence must be taken to validate phage
therapy for E. coli O157 :H7 control [42].
All postharvest interventions reported since 2000 have
been eﬀective in reducing E. coli levels from fresh produce
and meats. Also, phage application to E. coli contaminated
food contact surfaces has led to significant reductions
proving that phage can be used safely for equipment and
food contact surface sanitation.
The successful use of coliphages has led to the devel-
opment of a phage-product (EcoShield (Intralytix)) which
received regulatory approval from the Food and Drug
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Administration (FDA) in 2011. This product can be used
on red meat parts and trims intended to be ground (Food
Contact Notification no. 1018) and has proved to eliminate
from 95 to 100% of E. coli O157 :H7. Finalyse (Elanco Food
Solutions) is another product on the market using naturally
occurring phages specific for E. coli O157 :H7. Finalyse is
sprayed on cattle to reduce the load of E. coli, prior to its
entering the beef packing facility (preharvest strategy).
Campylobacter is a genus of gram-negative, spiral,
motile, and microaerophilic bacteria with an optimal growth
temperature around 41◦C. C. jejuni and C. coli members
are considered to be major aetiological agents of enteric
diseases worldwide. Campylobacter is the most commonly
reported zoonosis in Europe (EFSA 2011), and C. jejuni,
in particular, is estimated to cause approximately 845,000
illnesses, 8,400 hospitalizations, and 76 deaths each year
in the USA [1]. This widespread infection is explained
because ingestion of low doses (400–500 cells) [43] can cause
campylobacteriosis typically characterized by fever, bloody
diarrhea, and acute abdominal pain [44]. Campylobacter is
capable of colonizing the intestine of poultry and cattle,
and thus infection is mostly acquired by fecal-oral contact,
ingestion of contaminated foods (i.e., raw meat and milk
contaminated through feces), and waterborne through con-
taminated drinking water [45–47]. The widespread disease
and economic impact on agriculture and food industries has
led to the development of various approaches to contain this
infection using bacteriophages (Table 2).
Phage preharvest interventions reported so far have been
successful in reducing Campylobacter numbers in the cecal
content and feces of experimentally infected broilers and
have not caused any adverse health eﬀects. However, some
degree of resistant phenotypes, recovered from phage-treated
chickens, has been reported [48–50], of which some were
found to display clear evidence of genomic rearrangements
[51]. Scott and colleagues demonstrated that Campylobacter
virulent phages have the potential to activate dormant
prophages, leading to rapid pathogen evolution towards the
development of phage-resistant phenotypes. These authors
also showed that whilst pathogen evolution can be rapid,
resistance to the therapeutic bacteriophage is associated with
a decreased fitness to environment, specifically meaning
that phage-resistant phenotypes exhibited a decreased ability
to colonize the gastrointestinal tract [51]. These genomic
instability findings suggest thatC. jejuni adopt this strategy to
temporarily survive local environmental pressures, including
phage predation and competition for resources. The key ele-
ments for the success of phage therapy againstCampylobacter
in broiler chickens are a proper selection of phage, the dose
of phage applied, and the time elapsed after administration
[48].
As for postharvest strategies, two studies have been
reported (see Table 2) in which phages reduced Campy-
lobacter contamination following a “lysis from without”
mechanism. This suggests that Campylobacter phages can be
used as a tool for biocontrol purposes.
It is known that Campylobacter attaches and forms
biofilms on surfaces as ameasure to overcome environmental
stresses, such as aerobic conditions, desiccation, heating,
disinfectants, and acidic conditions frequently encountered
in food environments [52]; however, to date, we were
only able to find one report evaluating the eﬃcacy of
Campylobacter phages of disrupting biofilm formed on glass.
In this study, phages were able to reduce by 1 to 3 log the
viable cell counts under microaerobic conditions; however,
after treatment above 84% of the surviving bacteria were
resistant to the two phages applied [53].
Salmonella, is a genus of gram-negative facultative intra-
cellular species, is considered to be one of the principal
causes of zoonotic diseases reported worldwide. Salmonella
serovars can colonize and persist within the gastrointestinal
tract, and so human salmonellosis is commonly associated
with consumption of contaminated foods of animal origin.
Salmonella infections cost nearly 3 million euros in EU per
annum in health care systems [17, 54]. Salmonella enterica
serovars, Enteritidis and Typhimurium, are responsible for
the majority of Salmonella outbreaks, and most events are
reported to be due to consumption of contaminated eggs and
poultry, pig, and bovine meats, respectively [55]. Salmonella
is also a known spoilage bacterium in processed foods.
Once ingested, this microorganism can cause fever, diarrhea,
abdominal cramps, and even life-threatening infections [56].
To prevent such infections, a number of studies on animal
phage therapy have been reported where phages were used to
prevent or reduce colonization and diseases in livestock. All
recent studies are summarized in Table 3.
Phage therapy of experimentally Salmonella-infected
poultry and swine animals has been successful and sig-
nificantly decreased Salmonella in major tissues such as
ileum and cecal tonsils. Although these results have been
mostly obtained within contrived laboratory conditions, the
success of postslaughter phage employment, to lower the
risk of cross-contamination, will only be determined after
extending these studies to poultry farms.
Apart from one report in 2001, where the multivalent
Felix01 phage was used, all other in vivo experiments
performed recently were carried out using cocktails of two
to six phages. Furthermore, Ma and colleagues (2008) have
encapsulated phage Felix01 in a chitosan-coated Ca-alginate
spheres [57] and have found in in vitro studies that this
technique preserves phage viability upon exposure to acidic
conditions; however, to our knowledge, these encapsulated
phages have not yet been tested in vivo. Valuable outputs
have been made in the last couple of years in terms of
using phages for Salmonella biocontrol. Today, two phage-
products are available: (1) BacWash from OmniLytics Inc.
which received, in 2007, USDA’s Food Safety and Inspection
Services approval to be commercialized and applied as amist,
spray, or wash on live animals prior to slaughter; (2) BIO-
TECTOR S1 phage product from CheilJedang Corporation
that is to be applied on animal feed to control Salmonella in
poultry.
Unlike phage preharvest strategies on animals, several
postharvest strategies have adopted the use of only one phage
and not a cocktail. All Salmonella phages reported have
been able to decrease the number of viable cells present
on raw meats, processed and ready-to-eat foods, and fresh
produce. Furthermore, the combined treatment of phage
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Table 2: Pre- and postharvest Campylobacter phage applications.
Year Animal/product Phage(s) Strategy Main outcome Refs
Preharvest application
2005
Poultry
(broiler chickens)
ΦCP8, ΦCP34
Oral delivery in
antacid suspension
Decrease of CFU between 0.5 and 5 log CFU/g in the
cecal content over a 5-day period posttreatment
[48]
2005
Poultry
(broiler chickens)
69, 71 Oral delivery
Reduction of CFU by 1 log within 5-day period
post-treatment. Phage preventive treatment caused a
delay in a colonization
[58]
2009
Poultry
(broiler chickens)
CP220 Oral delivery
Reduction of 2 log CFU per g in cecal content after 48 h
inoculated C. jejuni and C. coli birds with a single dose
(7 log PFU) of CP220
[49]
2010
Poultry
(broiler chickens)
Phage cocktail
Oral delivery
(oral gavage and in
feed)
Reduction levels of C. coli and C. jejuni in feces by 2 log
CFU per g when administered by oral gavage and in
feed
[50]
Postharvest application
2003
Meat
(chicken skin)
Φ2 Applied on top
1 and 2 log CFU reduction at 4◦C using 107 PFU per
mL. 105 and 103 PFU per mL failed to decrease CFU
[58]
2003
Meat
(chicken skin)
Φ29C Applied on top
MOI 1 caused less than 1 log reduction in CFU; MOI
100–1,000 caused 2 log reductions in CFU
[49]
2008
Meat
(raw and cooked
beef)
Cj6 Applied on top
The largest reductions were recorded at high host cell
density on both raw and cooked beef over a period of 8
days incubation at 51◦C
[16]
and Enterobacter asburiae, a strain exhibiting antagonistic
activity against Salmonella, to control this pathogen on
tomatoes, mung bean sprouts, and alfalfa seeds, represents a
highly promising, chemical-free approach. However, in some
settings phages were found to be readily immobilized by the
food matrix and, although retaining infectivity, they lost the
ability to diﬀuse and infect target cells [59].
Listeria monocytogenes is a gram-positive, motile, and
facultative intracellular bacterium, that can grow under
several food matrices and storing conditions (e.g., high
salt levels, low pH, lack of oxygen, and low temperatures)
[60]. Invasive infection by L. monocytogenes causes listeriosis
and is transmitted to humans with 103 CFU/mL levels. It
is often associated with contaminated minimally processed
food such as ready-to-eat (RTE) products, poultry, and dairy
products or related to cross-contamination after the heat
treatment process of foods stored at low temperatures [61,
62]. Despite its low incidence, estimated to be in order of 2
of 10 reported cases per million per year in Europe [63], its
pathogenicity causes a high mortality rate of approximately
255 deaths each year in the USA alone according to the
Centers for Disease Control and Prevention (CDC) [1]. As
so, contingency measures have led to the establishment of a
limit for common RTE foods of 100 CFU per gram in EU and
a zero tolerance policy in the USA.
Considering the sources of Listeria outbreaks, phage
research has focused on postharvest applications (Table 4).
The first two studies in Table 4 were carried out using a
combination of phage and a nisin, a broad spectrum antibac-
teria peptide used during production to extend shelf life by
suppressing gram-positive spoilage and pathogenic bacteria.
While in ground beef the phage-nisin combination revealed
to be ineﬀective, this strategy had a synergistic eﬀect once
added to melon and apple resulting in an improved reduc-
tion of Listeria compared to phage or nisin alone. The eﬃcacy
of phage-nisin mixture was however significantly reduced in
apples on the account of a decline of phage numbers possibly
due to the low pH. Phage biocontrol should therefore be
optimized separately for each food matrices under study.
Four other studies have used phage P100, which was highly
eﬀective in inhibiting Listeria growth at storage temperatures
for several days (see Table 4). Like inCampylobacter, only one
article, by Soni and Nannapaneni (2010), on the eﬃcacy of
phages against biofilms was found for Listeria monocytogenes.
These authors evaluated the ability of P100 against 21 L.
monocytogenes strains belonging to 13 serotypes and found
that P100 reduced by 3.5 to 5.4 log/cm2 the viable cells
present in stainless steel surfaces [64]. Nonetheless, studies
carried out on a variety of experimentally contaminated
meats, fresh produce, and processed food among others
show that biocontrol is influenced by phage contact time
and phage dose, regardless of higher or lower temperature.
Despite this fact, the results conducted on RTE foods
and meats using LMP-102 phage preparation (six-phage
cocktail) allowed the commercialization of ListShield phage
product from Intralytix. Also, LISTEX P100 phage-based-
product (from EBI Food Safety) is being commercialized
with a GRAS status (generally recognized as safe) to prevent
Listeria contamination on food products and food processing
facilities.
Staphylococcus aureus is a gram-positive bacterium, is
considered to be a major threat to food safety [1, 90], and
also is the most common agent of mastitis in dairy cows [91].
CDC estimates that staphylococcal food poisoning, which
results from the consumption of foods containing suﬃcient
amounts of one or more preformed enterotoxins [91, 92],
is 242.148 cases annually in the USA [1]. The mechanisms
described for the contamination of foods with S. aureus can
be of animal or human origin, such as due to the infection
and colonization of livestock or farm workers and even
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Table 3: Pre- and postharvest Salmonella phage applications.
Year Animal/product Phage(s) Strategy Main outcome Refs
Preharvest application
2001
Poultry
(chicken)
Phage cocktail
Oral delivery
(direct and via feed)
Reduction of CFU in cecal counts between 0.3 and 1.3
log compared to controls birds
[65]
2001
Swine
(pig)
Felix01 Oral delivery and i.m. Reduction of CFU in the tonsils and cecum [66]
2005
Poultry
(broiler chickens)
CNPSA1,
CNPSA3, CNPSA4
Oral delivery Reduction of CFU by 3.5 orders of magnitude after five
days
[67]
2005
Poultry
(chickens)
Phage cocktail
(Sa2, S9, S11)
Oral delivery
phage/competitive
exclusion
Reduction of CFU in cecum and ileum after phage
cocktail and/or competitive exclusion treatment
[68]
2007
Poultry
(broiler chickens)
Φ151, Φ25, Φ10
Oral delivery
(antacid suspension)
Reduction of 4.2 log and 2.19 log with phages Φ151
and Φ25 within 24 h compared with control
[69]
2007
Poultry
(broiler chickens)
Phage cocktail
(CB4φ, WT45φ)
Oral delivery
Reduction of CFU in cecal tonsils after 24 h. No
significant diﬀerences at 48 h compered to controls
[70]
2008
Poultry
(chickens)
Phage cocktail
Oral delivery
(coarse
spray/drinking water)
Reduction of intestinal colonization of ten-day-old
experimentally contaminated birds
[71]
2010
Swine
(pig)
Phage cocktail
Reduction of colonization by 99.0 to 99.9% in the
tonsils, ileum, and cecum
[72]
2011
Swine
(weaned pigs)
Phage cocktail
Oral delivery
Significant reduction of CFU in the rectum [73]
2011
Poultry
(chickens)
Oral delivery
(via feed)
Phage prevented horizontal transmission on
six-week-old infected chickens
[74]
Postharvest application
2001
Processed food
(ripened cheese)
SJ2 Added to milk
No survival during 89 days in pasteurized cheeses
containing phages (MOI 104)
[75]
2001
Fresh produce
(fresh-cut melon
and apple)
Phage cocktail Added to foods Significant CFU reduction on melon but not on apple [76]
2003
Meat
(chicken skin)
P22, 29C Applied on top
MOI 1 caused less than 1 log reduction in CFU; MOI
100-1,000 caused 2 log reductions in CFU and
eradicated resistant strains
[13]
2003
Meat
(chicken
frankfurters)
Felix O1 Approx. 2 log reduction with a MOI of 1.9 × 104 [21]
2004
Fresh produce
(sprouting seeds)
A, B
Applied by
immersion
Phage-A reduced CFU by 1.37 logs on mustard seeds.
Cocktail resulted in a 1.5-log reduction in CFU in the
soaking water of broccoli seeds
[77]
2005
Meat
(broiler, turkey)
PHL 4 Sprayed
Phage treatments reduced frequency of Salmonella
recovery as compared with controls
[78]
2008
Meat
(raw/cooked beef)
P7 Applied on top
Reduction in CFU of 2-3 log at 5◦C and approx. 6 log at
24◦C
[16]
2009
Fresh produce
(tomatoes)
Phage cocktail
Phage + E. asburiae
JX1 added to food
Prevalence reduction of internalized S. Javiana,
although the major suppressing eﬀect was via
antagonistic activity of E. asburiae JX1
[79]
2010
Fresh produce
(mung bean
sprouts and alfalfa
seeds)
Phage cocktail
Phage + E. asburiae
JX1 added to foods
Combined biocontrol with E. asburiae and phage
suppressed pathogen growth on mung beans and alfalfa
seeds
[80]
2011
Meat
(pig skin)
Phage cocktail
(PC1)
Applied on top
Above 99% reduction in CFU for MOI of 10 or above at
4◦C for 96 h
[59]
2012
Ready-to-eat foods
and chocolate milk
FO1-E2
Added to foods and
mixed in milk
At 8◦C no viable cells. At 15◦C reduction of CFU by 5
logs on turkey deli meats and in chocolate milk and by
3 logs on hot dogs
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Table 4: Postharvest Listeria phage applications.
Year Product Phage(s) Strategy Main outcome Refs
2002
Meat (ground
beef)
Phage-nisin
mixture
Applied on top
Phage-nisin mixture was eﬀective in broth but not in
buﬀer or on raw beef
[81]
2003
Fresh produce
(melons, apples)
Phage cocktail
(LM-103, LM-102)
combined with
nisin
Applied on top or
sprayed
Phage caused a CFU reduction of 2.0 to 4.6 log in
melons and only 0.4 log in apples. Phage + nisin
reduced CFU by 5.7 (melon) and 2.3 (apple) log
[82]
2004
Fresh produce
(honeydew melon)
Phage cocktail Sprayed
Spraying melon pieces 0 h up to 1 h after Listeria
challenge reduced CFU by 6.8 log units after 7 days of
storage
[83]
2005
Processed food
(red-smear soft
cheese)
P100
Applied to surfaces
during the rind
washings
Reduction of CFU or complete eradication during the
rind washings
[84]
2009
Processed food
(cooked ham)
P100 Applied on top
Rapid 1 log reduction of CFU. 2 log reduction after 14
to 28 days of storage
[85]
2009
Fresh produce
(ready-to-eat
products)
A511, P100 Added to foods
In liquid foods, eradication of bacterial cells. On solid
foods reduction of CFU by up to 5 log
[86]
2010
Meat
(salmon fillet)
P100 Applied on top
Complete inhibition of growth at 4◦C for 12 days, at
10◦C for 8 days, and at 30◦C for 4 days
[64]
2010
Meat
(catfish fillets)
P100 Applied on top
Reduction of CFU by 1.4–2.0 log units at 4◦C, 1.7–2.1
logs at 10◦C, and 1.6–2.3 logs at 22◦C
[87]
2011
Processed food
(red-smear cheese)
A511 Applied on top
CFU counts dropped 3 logs after 22 days. Repeated
application of A511 further delayed re-growth
[88]
2011
Processed food
(ready-to-eat
chicken)
FWLLM1 Added to foods
Reduction of CFU by 2.5 log at 30◦C. At 5◦C, regrowth
was prevented over 21 days
[89]
due to the human handling of the food products [93]. S.
aureus can cause toxin-mediated diseases within 1 to 6 h after
consumption of contaminated foods; nevertheless the symp-
toms are usually mild and most people recover within 1–3
days [94]. The annual estimated loss worldwide due to mas-
titis in adult dairy cows is of 35 billion US dollars [95]. Phage
research has focused on the treatment of mastitis in lactating
dairy cows and mostly in dairy food products (Table 5).
The experimental work of phage therapy on dairy cattle
to control S. aureus on teats shows that, although there was
no increase in somatic cell counts in milk samples indicating
that the phages did not irritate the animal [96, 97], there were
no statistically diﬀerent outcomes between phage-treated
and placebo groups [97]. This suggests that the use of phage
as teat washes or sanitizers will not reduce the incidence
of S. aureus mostly due to the barriers to phage-mediated
bacteria lysis which are present in the bovine mammary
gland. The suggested reasons for the ineﬃcacy of phage K are
the degradation or inactivation of the phage particles within
the gland and the inhibitory eﬀects of raw milk [97]. Also,
it has been reported that milk whey prevents phages from
reaching their host cell surface [98] due to the agglutination
of S. aureus cells upon contact with raw whey [98, 99].
However, the work by Garcı´a et al. [100] on the use of
phages in curd manufacturing processes provides evidence
that phages are stable and active during enzymatic curd
formation suggesting that pH is, in fact, the most crucial
inactivation factor. Furthermore, these authors postulated
that the activity in milk of the phages used in their work was
due to their dairy origin.
Postharvest applications in pasteurized milk show that
the use of combined phage treatments with nisin and high
hydrostatic pressure could synergistically be used to reduce
staphylococcal contamination compared to each treatment
alone [101, 102]. Nevertheless, care should be taken in
regard to combined phage-nisin application since nisin-
adapted strains can seriously compromise phage activity
[101]. Inactivation of S. aureus has also been accomplished
in both fresh and hard-type cheese using a phage cocktail
during cheese manufacturing [103]. While for fresh cheese
staphylococcal cells could not be detectable until the end
of the curdling process (after 24 h), in hard cheeses, the
presence of staphylococcal strains continuously dropped to
1.24 log CFU per gram at the end of ripening [103] providing
evidence that phages can be successfully used to control S.
aureus in dairy food products.
Today, there are phage-based diagnostic tools available to
detect S. aureus, including antibiotic resistant (MRSA) and
susceptible (MSSA) strains (Microphage, Inc.).
Besides the five foodborne pathogens described above,
several other foodborne pathogens are responsible for ill-
nesses, hospitalizations, and deaths, such as Clostridium spp.,
Shigella spp., and Vibrio spp. Nonetheless, these are not
discussed further as to date there is a limited number of
articles on the use of phage against these pathogens.
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Table 5: Preharvest and Postharvest Staphylococcus aureus phage applications.
Year Animal/product Phage(s) Strategy Main outcome Refs
Preharvest application
2005
Ruminant (dairy
cattle)
K, CS1, DW2
Syringe applied
into the teat sinus
No detectable increase in somatic cell counts in milk [96]
2006
Ruminant
(lactating dairy
cattle)
K
Intramammary
infusions
Cure rate comparable in phage-treated and
saline-treated quarters. No large increase of somatic cell
count in the milk when phage was infused into quarters
with S. aureus infection
[97]
Postharvest application
2005
Raw and
ready-to-eat foods
(milk products and
derivatives)
K Added to milk
Phages adsorption was reduced in raw milk and
replication inhibited
[99]
2006
Raw food
(raw milk whey)
K
Added to raw milk
whey
Phage attachment and lysis inhibition due to
adsorption of whey proteins to the S. aureus cell.
[98]
2007
Processes food
(milk curd)
Cocktail (Φ88 and
Φ35)
Added to
pasteurized whole
milk
S. aureus not detectable after 4 h at 25◦C in acid curd
and total clearance within 1 h of incubation at 30◦C in
renneted curd. The addition of the phage cocktail to
milk prior to acid and enzymatic curd manufacture
eliminates S. aureus by up to 6 log units
[100]
2008
Ready-to-eat foods
(pasteurized milk)
Cocktail (Φ35,
Φ88) with nisin
Applied to foods
and mixed in milk
Nisin-phages application decreased S. aureus by 1 log
unit more than in each antimicrobial agent alone (24 h
at 37◦C). Nisin-resistant phenotypes acquired
resistance to phage, but phage resistance did not
necessarily confer nisin resistance
[101]
2012
Ready-to-eat foods
(pasteurized milk)
Cocktail
(philPLA35,
philPLA88 with
high hydrostatic
pressure (HHP)
Applied to foods
and added to milk
Combination of HHP and phage resulted in S. aureus
elimination within the 48 h regardless of the initial
contamination level (1 × 106 or 1 × 104 CFU per mL)
[102]
2012
Ready-to-eat foods
(cheese)
vB SauS-phi-
IPLA35,
vB SauS-phi-SauS-
IPLA88
Added to
pasteurized milk
vat
Phage cocktail led to undetectable limits of S. aureus
after 6 h in fresh cheese and continuous reductions in
hard cheese. In curd a reduction of 4.64 log CFU per g
was obtained compared with control
[103]
5. Concluding Remarks and Future Perspectives
Soon after the discovery of phages, several studies produced
negative results frequently associated with their inappro-
priate usage, including administration to treat viral and
unknown agent diseases. Now, when once more the potential
of phages is being evaluated mostly due to the increasing
emergence of multiresistant strains, it is important not to
repeat the same mistakes. Furthermore, the adoption of
phage administration and delivery routes, control proce-
dures, concentrations, and timings of application among
other parameters based on results found in the literature
must be done with caution as the eﬃcacy of each phage or
cocktail of phages is highly dependent on the phage-host
systems in study. Furthermore, sampling of experimentally
contaminated animals and foods and their treatment/control
with phage should mimic as much as possible the conditions
found at preharvest and postharvest (slaughterhouse, pro-
cessing, and at retail) stages. For example, to estimate the
input of the slaughterhouse into the process chain, samples
should be collected before and after cooling. Ready-to-eat
food usually undergoes several processing stages, and thus
it may be reasonable to verify the eﬃcacy of phage after
the process where phages were applied or, at least, at the
end of the processing stage. Nevertheless, it is well evident
that even after phage treatment, changes in food items still
occur during transport and storage. Future studies should
also focus on improving the general understanding of the
mechanisms of phage resistance acquired by the hosts and
the rate of elimination from the animal body. In addition,
further evaluation of phage for biosanitation purposes is still
not well documented for the pathogens listed above.
Although the results of the above-described studies
appear to be encouraging, they should be interpreted
cautiously. For instance, some phage studies have proven that
phages are ineﬃcient in reducing their host, such as phage
delivery on foods and drinking water for controlling E. coli
0157 :H7 in poultry and ruminants, and reduced eﬃcacy of
some of the phages reported. Also, the emergence of phage-
resistant phenotypes is reported by several authors; however
this has not significantly aﬀected the results of the phage tri-
als on animals and can be managed with using phages which
target those resistant phenotypes. Nonetheless, summarizing
briefly the results described recently: (i) phage therapy is
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able to reduce foodborne pathogen levels in animals and
consequently control the pathogen load on entry at the
slaughterhouses; (ii) the strategies applied for phage biocon-
trol of pathogens in foods reduce significantly the levels in a
variety of products and seem to be a promising alternative to
traditional food safety and preservation measures; (iii) phage
use in agricultural settings is as eﬃcient or more than the
conventionally used agents to control the growth of plant-
based bacterial pathogens. However, the future of phages in
food safety is further dependent on the regulatory agencies
that still display uneasiness with using phages, mostly due
to a scarcity of strong scientific evidence generated through
fully controlled clinical trials under the supervision of ethical
committees and in compliance with the highest regulatory
standards of leading Western jurisdictions [90]. Also, there is
a need to educate farmers, producers, and the general public
about the advantages of their use.
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